Analyst Ratings for Horizon Therapeutics (HZNP)
HZNP Rating Summary
HZNP Price Target Summary
- Highest: $116.50 (Jefferies)
- Lowest: $116.50 (Jefferies)
- Average: $116.50
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$116.50 (+0.2%)
* Over Last 12-Mos
Rating Score: 4.8 / 10
Percentile Rank: 48%
Avg. $ Target:
$116.50 (+0.2%)
* Over Last 12-Mos
Rating Score: 4.8 / 10
Percentile Rank: 48%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/1/2023 | Jefferies | Akash Tewar | Downgrade | Hold (Buy) |
116.50 (N/A) |
112.74 (116.30) |
3.16% | Details |
| 12/13/2022 | Leerink Partners | Joseph P. Schwartz | Downgrade | Market Perform (Outperform) |
N/A (N/A) |
112.36 (116.30) |
3.51% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
